Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Lifestyle changes can improve skin conditions and overall health.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

A patient's grey hair regained color during treatment with adalimumab.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

A woman got a skin condition from misusing a steroid cream, which improved after she stopped using it and started a new treatment.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.